Genetic Engineering in the Press by GEG
36.0K views | +0 today
Follow
Genetic Engineering in the Press by GEG
Your new post is loading...
Your new post is loading...
Scooped by BigField GEG Tech
Scoop.it!

Novartis, Gilead CAR-T therapies approved in Europe, putting spotlight on global manufacturing

Novartis, Gilead CAR-T therapies approved in Europe, putting spotlight on global manufacturing | Genetic Engineering in the Press by GEG | Scoop.it
BigField GEG Tech's insight:

Kymriah and Yescarta are churned out in a matter of weeks — a production task that gets more difficult as approvals expand their geographic reach.

No comment yet.
Scooped by BigField GEG Tech
Scoop.it!

Gilead’s CAR T-Cell Therapy Administered to Just Five Patients in Two Months

Gilead’s CAR T-Cell Therapy Administered to Just Five Patients in Two Months | Genetic Engineering in the Press by GEG | Scoop.it
More than 200 people are on waiting lists for the $373,000 treatment as hospitals try to work around problems with insurers. 
No comment yet.